This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lawrence Rice, MD
Baylor College of Medicine Houston

JAMA. 1980;244(23):2607-2608.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Inadequate construction of study and control groups by Marchand et al (1980;243:1909) inflates the apparent sensitivity and specificity of their serum haptoglobin assay. More important, there is no reason to believe that the test has much practical value.

Classification of megaloblastic anemia with hemolytic anemias advances the hypothesis of Marchand and coworkers, but it ignores that this is a problem of decreased RBC production because of ineffective erythropoiesis (intramedullary hemolysis); the shortened RBC survival contributes little to the anemia. It is then no wonder that Marchand and associates find little correlation between reticulocytosis and hemolysis, as megaloblastic anemia occurs with absolute reticulocytopenia. The control group of nonhemolytic diseases does not include other diseases characterized by ineffective erythropoiesis, such as sideroblastic anemia and agnogenic myeloid metaplasia. In hypersplenism, a disease that is clearly hemolytic, haptoglobin levels are normal, but only two such patients were studied. These factors greatly . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?